SCHEMBL5179733

SCHEMBL5179733

CC(C)=CCC/C(C)=C/C(P(=O)(O)O)P(=O)(O)O

nearest known ligand 0.59

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GGPS1 O95749 6/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20610011 0.96 GGPS1 (0.56) GGPS1
SCHEMBL7626203 0.80 FNTA (0.56) GGPS1
SCHEMBL7626511 0.80 GGPS1 (0.54) GGPS1
SCHEMBL6550106 0.80 GGPS1 (0.54) GGPS1
SCHEMBL7626199 0.80 FNTA (0.56) GGPS1
SCHEMBL8539459 0.80 GGPS1 (0.54) GGPS1
SCHEMBL9064176 0.80 GGPS1 (0.54) GGPS1
SCHEMBL536525 0.80 GGPS1 (0.54) GGPS1
SCHEMBL6550101 0.80 GGPS1 (0.54) GGPS1
SCHEMBL5068651 0.79 GGPS1 (0.46) GGPS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1793832-B1 GERANYLGERANYL PYROPHOSPHATE SYNTHASE INHIBITORS UNIV IOWA RES (US) 2014-07-23 EP disclosed
US-7268124-B2 Geranylgeranyl pyrophosphate synthase inhibitors UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) 2007-09-11 US disclosed
EP-1793832-A2 GERANYLGERANYL PYROPHOSPHATE SYNTHASE INHIBITORS University of Iowa Research (US) 2007-06-13 EP disclosed
US-20060052347-A1 Geranylgeranyl pyrophosphate synthase inhibitors UNIVERSITY OF IOWA RESEARCH FOUNDATION 2006-03-09 US disclosed
WO-2006026380-A2 GERANYLGERANYL PYROPHOSPHATE SYNTHASE INHIBITORS UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) 2006-03-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060052347-A1 Geranylgeranyl pyrophosphate synthase inhibitors GGPS1, FDPS, COASY GGPS1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.